Treatment of nonparaphilic hypersexuality in men with a long-acting analog of gonadotropin-releasing hormone

Journal of Sexual Medicine

Volumn 6, Issue 4, 2009, Pages 1151-1164

  Safarinejad, Mohammad R ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

GnRH Agonist; Hypersexuality; Male; Paraphilia; Treatment

Indexed keywords

DIPHERELINE; FOLLITROPIN; GONADORELIN DERIVATIVE; LUTEINIZING HORMONE; PROLACTIN; TESTOSTERONE; TRIPTORELIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANGINA PECTORIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASTHENIA; BACKACHE; BONE DENSITY; CACHEXIA; CONTROLLED STUDY; COUGHING; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; HAIR GROWTH; HOT FLUSH; HUMAN; HYPERSEXUALITY; INJECTION SITE PAIN; LIBIDO; MAJOR CLINICAL STUDY; MALE; PENIS ERECTION; PRIORITY JOURNAL; QUESTIONNAIRE; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SIDE EFFECT; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 63849243171     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2008.01119.x     Document Type: Article

References (69)

1. Shapiro MA, Chang YL, Munson SK, Okun MS, Fernandez HH. Hypersexuality and paraphilia induced by selegiline in Parkinson's disease: Report of 2 cases. Parkinsonism Relat Disord 2006;12:392-5.
2. Grabowska-Grzyb A, Naganska E, Wolanczyk T. Hypersexuality in two patients with epilepsy treated with lamotrigine. Epilepsy Behav 2006;8:663-5.
3. Ozmen M, Erdogan A, Duvenci S, Ozyurt E, Ozkara C. Excessive masturbation after epilepsy surgery. Epilepsy Behav 2004;5:133-6.
4. Higgins A, Barker P, Begley CM. Hypersexuality and dementia: Dealing with inappropriate sexual expression. Br J Nurs 2004;13:1330-4.
5. Nagaratnam N, Gayagay G Jr. Hypersexuality in nursing care facilities - A descriptive study. Arch Gerontol Geriatr 2002;35:195-203.
6. Wagner AW, Teri L, Orr-Rainey N. Behavior problems of residents with dementia in special care units. Alz Dis Assoc Dis 1995;9:121-7.
7. Coleman E, Kafka MP. Serotonin and paraphilias: The convergence of mood, impulse and compulsive disorders. J Clin Psychopharmacol 1991;11:223-4.
8. Kobayashi T. Effect of haloperidol on a patient with hypersexuality following frontal lobe injury. Psychogeriatrics 2004;4:49-52.
9. Hashimoto M, Akimoto T, Watanabe Y. Hypersexuality. Hypersexuality in persons with dementia. Nippon Rinsho 2004;62(4 suppl):67-72.
10. Chae BJ, Kang BJ. Quetiapine for hypersexuality and delusional jealousy after stroke. J Clin Psychopharmacol 2006;26:331-2.
11. American Psychological Association. Diagnostic and statistical manual of mental disorders (4th ed.) text revision. New York: American Psychiatric Press; 2000.
12. Haslam D, Adam S, Oluboka O. Re: The neurobiology, neuropharmacology, and pharmacologic treatment of paraphilias and compulsive sexual behaviour. Can J Psychiatry 2001;46:559.
13. Saleh FM, Niel T, Fishman MJ. Treatment of paraphilia in young adults with leuprolide acetate: A preliminary case report series. J Forensic Sci 2004;49:1343-8.
14. Goodman A. Diagnosis and treatment of sexual addiction. J Sex Marital Ther 1993;19:225-51.
15. Kafka MP, Hennen J. Hypersexual desire in males: Are males with paraphilias different from males with paraphilia-related disorders? Sex Abuse 2003;15:307-21.
16. Hoogeveen J, Van der Veer E. Side effects of pharmacotherapy on bone with long-acting gonadorelin agonist triptorelin for paraphilia. J Sex Med 2008;5:626-30.
17. Maletzky BM. Castration: A personal foul. Sex Abuse 1997;9:1-5.
18. van der Meer T. Eugenic and sexual folklores and the castration of sex offenders in the Netherlands (1938-1968). Stud Hist Philos Biol Biomed Sci 2008;39:195-204.
19. Maletzky BM, Fiel G. The biological treatment of dangerous sexual offenders, a review and preliminary report of the Oregon pilot depo-Provera program. Aggress Violent Behav 2003;8:391-412.
20. Rösler A, Witztum E. Treatment of men with paraphilia with a long-acting analogue of gonadotropin releasing hormone. N Engl J Med 1998;338:416-22.
21. Grubin D. Sexual offending and treatment of sex offenders. Psychiatry 2004;3:17-21.
22. Stahl SM. Essential psychopharmacotherapy: Neuroscientific basis and practical applications. Cambridge: Cambridge University Press; 2000.
23. Horvitz JC, Ettenberg A. Haloperidol blocks the response-reinstating effects of food reward: A methodology for separating neuroleptic effects on reinforcement and motor processes. Pharmacol Biochem Behav 1989;31:861-5.
24. Stewart JT, Shin KJ. Paroxetine treatment of sexual disinhibition in dementia. Am J Psychiatry 1997;154:1474.
25. McKillop C. Interview with Professor Ulf Tunn: LHRHa: What's new? Interview by Christine McKillop. Eur Urol 2007;51:275-7.
26. Briken P, Nika E, Berner W. Treatment of paraphilia with luteinizing hormone-releasing hormone agonists. J Sex Marital Ther 2001;27:45-55.
27. Rösler A, Witztum E. Treatment of men with paraphilia with a long-acting analogue of gonadotropin-releasing hormone. N Engl J Med 1998;338:416-22.
28. Kaplan HI, Saddock BJ, Grebb JA. Synopsis of psychiatry. 7th edition. Balitmore, MD: Williams & Wilkins; 1994.
29. World Health Organization. The ICD-10 classification of mental and behavioural disorders diagnostic criteria for research. Geneva, Switzerland: World Health Organization; 1993.
30. World Health Organization. WHO Laboratory manual for the examination of human semen-cervical mucus interaction, (3rd ed.). Cambridge: Cambridge University Press; 1992.
31. Kruger TF, Menkveld R, Stander FS, Lombard CJ, Van der Merwe JP, Van Zyl JA, Smith K. Sperm morphologic features as a prognostic factor in in vitro fertilization. Fertil Steril 1986;46:1118-23.
32. Obara H, Shibahara H, Tsunoda H, Taneichi A, Fujiwara H, Takamizawa S, Idei S, Sato I. Prediction of unexpectedly poor fertilization and pregnancy outcome using the strict criteria for sperm morphology before and after sperm separation in IVF-ET. Int J Androl 2001;24:102-8.
33. Oehninger S, Acosta AA, Morshedi M, Veeck L, Swanson RJ, Simmons K, Rosenwaks Z. Corrective measures and pregnancy outcome in in vitro fertilization in patients with severe sperm morphology abnormalities. Fertil Steril 1988;50:283-7.
34. Kruger TF, Swanson RJ, Hamilton M, Simmons KF, Acosta AA, Matta JF, Oehniger S, Morshedi M. Abnormal sperm morphology and other semen parameters related to the outcome of the hamster oocyte human sperm penetration assay. Int J Androl 1988;11:107-13.
35. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997;49:822-30.
36. Morelli A, Marini M, Mancina R, Luconi M, Vignozzi L, Fibbi B, Filippi S, Pezzatini A, Forti G, Vannelli GB, Maggi M. Sex steroids and leptin regulate the "first Kiss" (KiSS 1/G-protein-coupled receptor 54 system) in human gonadotropin-releasing-hormone-secreting neuroblasts. J Sex Med 2008;5:1097-113.
37. Cannas A, Solla P, Floris G, Tacconi P, Loi D, Marcia E, Marrosu MG. Hypersexual behaviour, frotteurism and delusional jealousy in a young parkinsonian patient during dopaminergic therapy with pergolide: A rare case of iatrogenic paraphilia. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:1539-41.
38. Malladi SS, Singh AN. Hypersexuality and its response to citalopram in a patient with hypothalamic hamartoma and precocious puberty. Int J Neuropsychopharmacol 2005;8:635-6.
39. Cummings JL, Benson DF. Dementia: A clinical approach. 2nd edition. Boston, MA: Butterworth-Heinemann; 1992.
40. Robinson KM. Understanding hypersexuality: A behavioral disorder of dementia. Home Healthc Nurse 2003;21:43-7.
41. Varker Y, Devilly GJ, Ward T, Beech AR. Empathy and adolescent sexual offenders: A review of the literature. Aggress Violent Behav 2008;13:251-60.
42. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition. Washington, DC: American Psychiatric Association; 1994.
43. Kafka MP. A monoamine hypothesis for the pathophysiology of paraphilic disorders: An update. Ann N Y Acad Sci 2003;989:86-94.
44. Krueger RB, Kaplan MS. The paraphilic and hypersexual disorders: An overview. J Psychiatr Pract 2001;7:391-403.
45. Cummings JL. Neuropsychiatry. Clinical assessment and approach to diagnosis. In: Kaplan HI, Saddock BJ, eds. Comprehensive textbook of psychiatry/VI. 6th edition. Baltimore, MD: Williams and Wilkins; 1995:185-6.
46. Shapiro MA, Chang YL, Munson SK, Okun MS, Fernandez HH. Hypersexuality and paraphilia induced by selegiline in Parkinson's disease: Report of 2 cases. Parkinsonism Relat Disord 2006;12:392-5.
47. Munhoz RP, Fabiani G, Becker N, Teive HA. Increased frequency and range of sexual behavior in a patient with Parkinson's disease after use of pramipexole: A case report. J Sex Med 2008 [Epub ahead of print].
48. Grabowska-Grzyb A, Naganska E, Wolanczyk T. Hypersexuality in two patients with epilepsy treated with lamotrigine. Epilepsy Behav 2006;8:663-5.
49. Rellini A. Review of the empirical evidence for a theoretical model to understand the sexual problems of women with a history of CSA. J Sex Med 2008;5:31-46.
50. Proulx J, Ouimet M, Pellerin MSc, Paradis Y, McKibben A, Aubut J. Post treatment recidivism rates in sexual aggressors - A comparison between dropout and nondropout subjects. In: Schwartz BK, ed. The sex offender: Theoretical advances, treating special populations and legal developments. Kingston, NJ: Civic Research Institute; 1999:15-1-13.
51. Farkas MA, Stichman A. Sex offender laws: Can treatment, punishment, incapacitation, and public safety to be reconciled? Crim Just Rev 2002;27:256-83.
52. Harkins L, Beech AR A review of the factors that can influence the effectiveness of sexual offender treatment: Risk, need, responsivity, and process issues. Aggress Violent Behav 2007;12:615-27.
53. Marshall WL. Assessment, treatment, and theorizing about sex offenders: Developments during the past twenty years and future directions. Crim Justice Behav 1996;23:162-99.
54. Beech AR, Fisher DD. Treatment of sex offenders in the UK in prison and probation services. In: Kemshall H, McIvor G, eds. Managing sex offender risk. London: Jessica Kingsley Publishers; 2004:137-63.
55. Carich MS, Mussack SE, eds. Handbook for sexual abuser assessment and treatment. Brandon, VT: Safer Society Press; 2001.
56. Winton MA. The medicalization of male sexual dysfunctions: An analysis of sex therapy journals. J Sex Educ Ther 2000;25:231-9.
57. Doren DM, Yates PM. Effectiveness of sex offender treatment for psychopathic sexual offenders. Int J Offender Ther Comp Criminol 2008;52:234-45.
58. Schmucker M, Lösel F. Does sexual offender treatment work? A systematic review of outcome evaluations. Psicothema 2008;20:10-9.
59. Stürup GK. Treatment of sexual offenders in Herstedvester Denmark. The rapists. Acta Psychiatr Scand Suppl 1968;204:5-62.
60. Brett MA, Roberts LF, Johnson TW, Wassersug RJ. Eunuchs in contemporary society: Expectations, consequences, and adjustments to castration (part II). J Sex Med 2007;4:946-55.
61. Heim N, Hursch CK. Castration for sex offenders: Treatment or punishment? A review and critique of recent European literature. Arch Sex Behav 1979;8:281-304.
62. Johnson TW, Brett MA, Roberts LF, Wassersug RJ. Eunuchs in contemporary society: Characterizing men who are voluntarily castrated (part I). J Sex Med 2007;4:930-45.
63. Reitzel LR, Carbonell JL. The effectiveness of sexual offender treatment for juveniles as measured by recidivism: A meta-analysis. Sex Abuse 2006;18:401-21.
64. Levitsky AM, Owens NJ. Pharmacologic treatment of hypersexuality and paraphilias in nursing home residents. J Am Geriatr Soc 1999;47:231-4.
65. Katz D. Psychopharmacological interventions with adolescent and adult sex offenders. In: Shaw JA, ed. Sexual aggression. Washington, DC: American Psychiatric Press; 1999:305-26.
66. Keeling JA, Beech AR, Rose JL. Assessment of intellectually disabled sexual offenders: The current position. Aggress Violent Behav 2007;12:229-41.
67. Fong TW, De La Garza R 2nd, Newton TF. A case report of topiramate in the treatment of nonparaphilic sexual addiction. J Clin Psychopharmacol 2005;25:512-4.
68. Gondim FA, Thomas FP. Episodic hyperlibidinism in multiple sclerosis. Mult Scler 2001;7:67-70.
69. Kafka MP. Hypersexual desire in males: An operational definition and clinical implications for males with paraphilias and paraphilia-related disorders. Arch Sex Behav 1997;26:505-26.